Abstract
Atopic eczema (AE) is a chronic inflammatory skin disorder characterized by eczematous skin lesions, pruritus and typical histopathological features. Although T cells play a key role, B cells are also found in the dermal infiltrate. In 80% of AE patients, elevated total and specific IgE levels can be detected. This study aimed to investigate the effect of a monoclonal anti-CD20 antibody therapy (rituximab) in AE.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
